Meitheal Pharmaceuticals recently launched two new generics. The company released alprostadil injection 500 mcg/ml single-dose vials to the U.S. market, where only an ampoule form is offered. The ...
Meitheal Pharmaceuticals has gotten federal approval for a new kind of antibiotic for use on hospitalized patients with urinary tract infections, a major step in the Chicago biopharma company's ...
Meitheal, through parent company Hong Kong King-Friend, launches generic paclitaxel Protein-bound paclitaxel formulation is used to treat various types of cancer, including metastatic breast cancer ...